Key result
Large, simple clinical trials remain essential for determining the long-term balance of risk and benefit in chronic conditions, as many current trials are too small to provide reliable estimates.
Answers are grounded in this paper and cite their sources.
The authors argue for the necessity of large, simple trials to accurately determine the long-term risk-benefit balance of treatments for chronic conditions, despite the growing interest in smaller, personalized medicine trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eapen et al. (2014) conducted an editorial in Chronic illnesses. Large, simple clinical trials remain essential for determining the long-term balance of risk and benefit in chronic conditions, as many current trials are too small to provide reliable estimates.
Synapse has enriched 10 related papers. Consider them for comparative context: